2.13 BONUS! RCTs Supporting Approvals of Cancer Drugs by EMA with Dr. Huseyin Naci
On this week's BONUS episode, we sit down with Dr…
Plenary Session - inactive due to federal service · Plenary Session - inactive due to federal service
September 20, 201939m 32sExplicit
Audio is streamed directly from the publisher (feeds.soundcloud.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
On this week's BONUS episode, we sit down with Dr. Huseyin Naci, Assistant Professor of Health Policy at the London School of Economics, to discuss his new paper that came out Wednesday (producer's edit: not "yesterday" as said in the podcast - apologies for the delay!) in the British Medical Journal. The paper's titled "Design characteristics, risk of bias, and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency, 2014-16: cross sectional analysis."
RCTS Supporting Approvals: doi.org/10.1136/bmj.l5221
Back us on Patreon! patreon.com/plenarysession
Topics
medicineoncologyhealthpolicy